echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Price reduction into the mainstream, high-priced drug procurement will be focused on monitoring

    Price reduction into the mainstream, high-priced drug procurement will be focused on monitoring

    • Last Update: 2020-11-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    "Pharmaceutical Network Industry Dynamics" Recently, Jiangsu Provincial Health Insurance Bureau issued "on the further improvement of the drug sunshine hanging network norms and price early warning management related matters notice", said to further guide enterprises to standardize the hanging network, in-depth promotion of drug sunshine procurement work.
    From the specific point of view of the notice, Jiangsu Province adopted the "four rules" to squeeze out the drug price moisture, including generic drug network prices should not be higher than the corresponding original drug, the implementation of drug price differential rules, the new approval of registered drug negotiations for the provincial platform has been hung the same drug floor price, temporarily do not accept suspended, revoked the hanging network of drugs online declaration.
    In addition, Jiangsu Province in the document also requires the use of "red, yellow and blue" three-color reminder to medical institutions to remind, supervise and assess the bargaining results of different products of the same variety of dynamic monitoring and analysis, the price warning included in the scope of drug bargaining warning warning or reminder, to promote medical institutions to take the initiative to bargain.
    For medical institutions with large quantities of drug procurement in the red areas with large proportions of long-term non-bargaining and bargaining results, and the top medical institutions in the procurement volume of red early warning drugs, the medical insurance department shall interview and supervise rectification according to the circumstances.
    For the above content, industry analysis that Jiangsu Province this time obviously to do more refined medical insurance procurement, although there is no clear notice, standard clearance official start time, requirements, but according to the previous Jiangsu to reduce drug prices, linked to the national low-cost drug sunshine online drug prices for the first round of adjustment results, it is expected that the future of Jiangsu Province drug market will be a major adjustment, a large number of pharmaceutical companies or will be affected.
    it is understood that in Jiangsu Province before the first round of drug price adjustment of the drug sunshine hanging network, there are 12,327 drugs to reduce the price of the network, an average decrease of 5.54%, the adjusted price has been implemented since June 1.
    the province is expected to save 4 billion yuan a year in procurement funds.
    , it is worth noting that this time Jiangsu Province requires the play of "red, yellow and blue" three-color reminder is not a special case.
    As early as last October, Shanghai began to implement the public bargaining procurement of drug registration network, clear flow labels and shortage of drugs can be applied for in Shanghai Sunshine procurement platform, there are documents for hospitals and pharmaceutical companies to bargain, Shanghai Sunshine procurement platform will be set up green, yellow and red lines to remind.
    on June 30, this year, Shanghai issued the "Strengthening the drug network open bargaining procurement supervision tips."
    the document said that it will further strengthen the drug network open bargaining procurement supervision work, and the bargaining ultra-yellow line of drugs into the scope of key supervision.
    In addition, the document also said that the Shanghai Pharmaceutical Institute will be monthly through the "Shanghai Sunshine Pharmaceutical Procurement Network" statistical results, published the price of ultra-yellow line varieties of medical institutions ranking and the price increase of higher varieties of the ranking.
    can be clearly seen from the above, under the monitoring of big data, high-priced drugs are getting more and more difficult! In fact, from the current national policy orientation, as well as local response policies, the introduction of regulatory documents, drug price reduction is the mainstream.
    industry expects that in the future, under the deterrent of publicity, interviews, health care and other measures, or will urge hospitals and pharmaceutical companies to negotiate prices, directly at lower prices to negotiate, further saving procurement funds.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.